Calmare Therapeutics Inc (fka CTTC)

[Spocks Stocks]

V-c

Not confortable with your characterization of those trials as competitive with Calmare. Those are trials to try to reduce the rate or intensity of CIPN in chemo patients. While you may have just invented a new use for Calmare (use with chemo as a preventative), that is really a totally different market opportunity that treatment of CIPN who have failed medical therapy.

I also notice you praised and put up a poster on another recently FDA cleared technology for pain. What you didnt mention was that at 6 months, with the limited data pain was reduced 40% in the treatment group and 37% in the placebo. Now this was not an equivalent group of patients (ie, not candidates for Calmare) but I wonder why praised that technology and study?